Source link : https://newshealth.biz/health-news/evolution-of-perioperative-immunotherapy-in-resectable-esophageal-cancer/
The emergence of immunotherapy for esophageal cancer provided a glimmer of hope to patients and clinicians affected by the historically poor-prognosis disease. The glimmer has not only persisted but perhaps grown brighter as immunotherapy’s role in esophageal cancer has evolved and expanded over the past 7 years. The FDA granted accelerated approval to pembrolizumab (Keytruda) […]
The post Evolution of Perioperative Immunotherapy in Resectable Esophageal Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-23 21:31:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8